|
SolarazeDrug - Solaraze The trade name of the product as shown on the labeling.
Dosage -
GEL; TOPICAL
Active Ingredient(s) -
Diclofenac Sodium
Strength -
3%
Applicant -
BIOGLAN PHARMS CORP
New Drug Application (NDA) Number -
021005
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Oct 16, 2000
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Bioglan Pharms Corp Dba Doak Dermatologics
Solaraze
Cataflam 50mg Tablet; Oral
Diclofenac Potassium 50mg Tablet; Oral Diclofenac Potassium 50mg Tablet; Oral Diclofenac Potassium 50mg Tablet; Oral Diclofenac Potassium 50mg Tablet; Oral Diclofenac Potassium 50mg Tablet; Oral Diclofenac Potassium 50mg Tablet; Oral Diclofenac Potassium 50mg Tablet; Oral Solaraze 3% Gel; Topical Cataflam 25mg **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Tablet; Oral NewDrugInformation |